186 related articles for article (PubMed ID: 31017643)
1. Association of PDGFRB Mutations With Pediatric Myofibroma and Myofibromatosis.
Dachy G; de Krijger RR; Fraitag S; Théate I; Brichard B; Hoffman SB; Libbrecht L; Arts FA; Brouillard P; Vikkula M; Limaye N; Demoulin JB
JAMA Dermatol; 2019 Aug; 155(8):946-950. PubMed ID: 31017643
[TBL] [Abstract][Full Text] [Related]
2. PDGFRB gain-of-function mutations in sporadic infantile myofibromatosis.
Arts FA; Sciot R; Brichard B; Renard M; de Rocca Serra A; Dachy G; Noël LA; Velghe AI; Galant C; Debiec-Rychter M; Van Damme A; Vikkula M; Helaers R; Limaye N; Poirel HA; Demoulin JB
Hum Mol Genet; 2017 May; 26(10):1801-1810. PubMed ID: 28334876
[TBL] [Abstract][Full Text] [Related]
3. Corneal Infantile Myofibromatosis Caused by Novel Activating Imatinib-Responsive Variants in
Howaldt A; Lenglez S; Velmans C; Schultheis AM; Clahsen T; Matthaei M; Kohlhase J; Vokuhl C; Büttner R; Netzer C; Demoulin JB; Cursiefen C
Ophthalmol Sci; 2024; 4(3):100444. PubMed ID: 38374928
[TBL] [Abstract][Full Text] [Related]
4. Recurrent Somatic PDGFRB Mutations in Sporadic Infantile/Solitary Adult Myofibromas But Not in Angioleiomyomas and Myopericytomas.
Agaimy A; Bieg M; Michal M; Geddert H; Märkl B; Seitz J; Moskalev EA; Schlesner M; Metzler M; Hartmann A; Wiemann S; Michal M; Mentzel T; Haller F
Am J Surg Pathol; 2017 Feb; 41(2):195-203. PubMed ID: 27776010
[TBL] [Abstract][Full Text] [Related]
5. Infantile Myofibromatosis With Intracranial Extradural Involvement and PDGFRB Mutation: A Case Report and Review of the Literature.
Al Qawahmed R; Sawyer SL; Vassilyadi M; Qin W; Boycott KM; Michaud J
Pediatr Dev Pathol; 2019; 22(3):258-264. PubMed ID: 30103666
[TBL] [Abstract][Full Text] [Related]
6. PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinib.
Arts FA; Chand D; Pecquet C; Velghe AI; Constantinescu S; Hallberg B; Demoulin JB
Oncogene; 2016 Jun; 35(25):3239-48. PubMed ID: 26455322
[TBL] [Abstract][Full Text] [Related]
7. Solitary myofibroma preceding the development of multicentric myofibromatosis: A report of two cases with surveillance recommendations.
Todd K; Kim HK; Szabo S; Johnson S; Pressey J; Nagarajan R; Sorger J; Dasgupta R; Turpin B
Pediatr Blood Cancer; 2020 Oct; 67(10):e28266. PubMed ID: 32618426
[TBL] [Abstract][Full Text] [Related]
8. A Distinctive Genomic and Immunohistochemical Profile for NOTCH3 and PDGFRB in Myofibroma With Diagnostic and Therapeutic Implications.
Koo SC; Janeway KA; Harris MH; Fryer CJ; Aster JC; Al-Ibraheemi A; Church AJ
Int J Surg Pathol; 2020 Apr; 28(2):128-137. PubMed ID: 31566039
[No Abstract] [Full Text] [Related]
9. PDGFRB and NOTCH3 Mutations are Detectable in a Wider Range of Pericytic Tumors, Including Myopericytomas, Angioleiomyomas, Glomus Tumors, and Their Combined Tumors.
Iwamura R; Komatsu K; Kusano M; Kubo C; Inaba Y; Shiba E; Nawata A; Tajiri R; Matsuyama A; Matoba H; Koga K; Takeda M; Itami H; Hisaoka M
Mod Pathol; 2023 Mar; 36(3):100070. PubMed ID: 36788105
[TBL] [Abstract][Full Text] [Related]
10. Novel
Hassan M; Butler E; Wilson R; Roy A; Zheng Y; Liem P; Rakheja D; Pavlick D; Young LL; Rosenzweig M; Erlich R; Ali SM; Leavey PJ; Parsons DW; Skapek SX; Laetsch TW
Cold Spring Harb Mol Case Stud; 2019 Oct; 5(5):. PubMed ID: 31645346
[TBL] [Abstract][Full Text] [Related]
11. Myopericytomatosis: Clinicopathologic Analysis of 11 Cases With Molecular Identification of Recurrent PDGFRB Alterations in Myopericytomatosis and Myopericytoma.
Hung YP; Fletcher CDM
Am J Surg Pathol; 2017 Aug; 41(8):1034-1044. PubMed ID: 28505006
[TBL] [Abstract][Full Text] [Related]
12. [Myofibroma/myofibromatosis: a clinicopathologic analysis of 9 cases].
Fu Y; Guan WY; Wu HY; Wu HY; Fan ZW; Ye Q; Meng FQ
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):45-50. PubMed ID: 29325250
[No Abstract] [Full Text] [Related]
13. Solitary adult orbital myofibroma: Report of a case and review of the literature.
Morrow NC; Tanas MR; Syed NA; Rajan Kd A
Am J Ophthalmol Case Rep; 2020 Dec; 20():100955. PubMed ID: 33089011
[TBL] [Abstract][Full Text] [Related]
14. Genetic testing and surveillance in infantile myofibromatosis: a report from the SIOPE Host Genome Working Group.
Hettmer S; Dachy G; Seitz G; Agaimy A; Duncan C; Jongmans M; Hirsch S; Kventsel I; Kordes U; de Krijger RR; Metzler M; Michaeli O; Nemes K; Poluha A; Ripperger T; Russo A; Smetsers S; Sparber-Sauer M; Stutz E; Bourdeaut F; Kratz CP; Demoulin JB
Fam Cancer; 2021 Oct; 20(4):327-336. PubMed ID: 32888134
[TBL] [Abstract][Full Text] [Related]
15. Aggressive infantile myofibromatosis with intestinal involvement.
Römer T; Wagner N; Braunschweig T; Meyer R; Elbracht M; Kontny U; Moser O
Mol Cell Pediatr; 2021 Jun; 8(1):7. PubMed ID: 34132909
[TBL] [Abstract][Full Text] [Related]
16. Novel COL4A1-VEGFD gene fusion in myofibroma.
Dachy G; Fraitag S; Boulouadnine B; Cordi S; Demoulin JB
J Cell Mol Med; 2021 May; 25(9):4387-4394. PubMed ID: 33830670
[TBL] [Abstract][Full Text] [Related]
17. The spectrum of infantile myofibromatosis includes both non-penetrance and adult recurrence.
Murray N; Hanna B; Graf N; Fu H; Mylène V; Campeau PM; Ronan A
Eur J Med Genet; 2017 Jul; 60(7):353-358. PubMed ID: 28286173
[TBL] [Abstract][Full Text] [Related]
18. Clinico-pathologic correlations of myofibroblastic tumors of the oral cavity. II. Myofibroma and myofibromatosis of the oral soft tissues.
Vered M; Allon I; Buchner A; Dayan D
J Oral Pathol Med; 2007 May; 36(5):304-14. PubMed ID: 17448141
[TBL] [Abstract][Full Text] [Related]
19. Activating variants in PDGFRB result in a spectrum of disorders responsive to imatinib monotherapy.
Wenger TL; Bly RA; Wu N; Albert CM; Park J; Shieh J; Chenbhanich J; Heike CL; Adam MP; Chang I; Sun A; Miller DE; Beck AE; Gupta D; Boos MD; Zackai EH; Everman D; Ganapathi S; Wilson M; Christodoulou J; Zarate YA; Curry C; Li D; Guimier A; Amiel J; Hakonarson H; Webster R; Bhoj EJ; Perkins JA; Dahl JP; Dobyns WB
Am J Med Genet A; 2020 Jul; 182(7):1576-1591. PubMed ID: 32500973
[TBL] [Abstract][Full Text] [Related]
20. High-Grade Sarcomas with Myogenic Differentiation Harboring Hotspot PDGFRB Mutations.
Dermawan JK; Chiang S; Hensley ML; Tap WD; Antonescu CR
Mod Pathol; 2023 May; 36(5):100104. PubMed ID: 36788091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
